Better Dividend Stock: AbbVie or Pfizer?
Both of these big pharma stocks have plenty to offer investors.
Mindfully Curated
Both of these big pharma stocks have plenty to offer investors.

Hoda Afshar’s images capture craggy, Martian-red rock formations and poetic moments of communion between individuals and landscapes.

Though created nearly 60 years ago, her artworks feel exuberantly contemporary.
Three key factors make all the difference in determining how large your Social Security benefit will get.
You can, but there’s a bit more to it than just picking stocks or funds.
Spinoffs of self-driving companies could unlock a lot of value for big auto shareholders. Are they likely?
The aerospace titan can’t seem to get out of its own way, with major technical miscues across the enterprise.
Damien Peters, founder of Wealth Noir, explains a tricky part of home-buying and how to be prepared.
Accenture, EPAM Systems, and CDW just reported earnings. Here’s what we’re tracking with these digital stalwarts.
It wasn’t about the semiconductors.
KeyCorp looks to be heading in a good direction with its national digital bank, and it also has strong fundamentals behind its business.
Damien Peters, founder of Wealth Noir, on how to boost your top-line and build generational wealth faster.
Damien Peters, founder of Wealth Noir, on why you should buy a stock today, even if you aren’t flush with cash.
Avoiding crucial missteps can make you much richer over the long term.
Nvidia is one of several big-name stocks set to announce earnings results over the next few days.
Management’s execution has been superb, and the fundamentals look excellent.
You may land in a scenario where you have to file for benefits in the absence of having an income. But if those circumstances change, here’s one move worth making.
These stocks could help you shrug off the next market crash.
This is a hefty price to pay, but is Square getting its money’s worth?
These drugmakers are built for the long run.